Copertina

Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Swastika Maitra, Subham Sarkar, Bikram Dhara
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical and Translational Discovery
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Modified plant‐derived exosomes: Precision medicine in cancer treatment
di: Swastika Maitra, et al.
Pubblicazione: (2024)

Sweat exosomes: A new cutting edge nanomedicine in cancer treatment
di: Bikram Dhara, et al.
Pubblicazione: (2024)

Liquid biopsy—A biomarker‐based revolutionising technique in cancer therapy
di: Subham Sarkar, et al.
Pubblicazione: (2024)

Plant exosomes: A natural medicine for oral cancer
di: Sidhanti Nyahatkar, et al.
Pubblicazione: (2024)

Plant‐derived exosomes: A Green Nanomedicine for Cancer
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Milk exosomes: Harnessing nature's duality for cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

Engineered cell versus modified exosomes in cancer therapy
di: Rajib Dhar, et al.
Pubblicazione: (2024)

Tumor and cancer stem cells‐derived exosomes interplay: A secret of cancer complications
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Clinical signature of exosomal tetraspanin proteins in cancer
di: Asmit Das, et al.
Pubblicazione: (2024)

The prospective trajectory of exosomes‐based cancer nanomedicine
di: Divya Mirgh, et al.
Pubblicazione: (2024)

Clinical trial status of exosomes‐based cancer theranostics
di: Swarup Sonar
Pubblicazione: (2024)

Signature of click chemistry in exosome modification for cancer therapeutic
di: Nobendu Mukerjee, et al.
Pubblicazione: (2024)

Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
di: Jiaqi Liang, et al.
Pubblicazione: (2025)

Nanomedicine: a frontier of the breast cancer treatment
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

Mesenchymal stem cell therapy for ulcerative colitis: Opportunities and challenges in precision medicine
di: Peng‐Fei Wang, et al.
Pubblicazione: (2025)

Stereo cell: A new approach to the next generation of clinical precision medicine
di: Wanxin Duan, et al.
Pubblicazione: (2025)

Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics
di: Yue Zhao, et al.
Pubblicazione: (2026)

Effects of microRNA on the growth and targeted therapy response on lung cancer
di: Mengchen Zhu, et al.
Pubblicazione: (2024)

Intervertebral disc degeneration and regenerative medicine
di: Mariam Farag, et al.
Pubblicazione: (2024)

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
di: Fansen Ji, et al.
Pubblicazione: (2025)

Significance of stereologically spatiotemporal cells in molecular medicine
di: Xuanqi Liu, et al.
Pubblicazione: (2025)

Clinical marine biomedicine: An emerging area in clinical and translational medicine
di: Xiaojun Yan, et al.
Pubblicazione: (2025)

Advancing precision medicine through single‐cell sequencing: Insights and implications
di: Xu Zhang, et al.
Pubblicazione: (2024)

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
di: Xinni Chen, et al.
Pubblicazione: (2026)

Single‐cell and spatial alterations of neural cells and circuits in clinical and translational medicine
di: William Wang, et al.
Pubblicazione: (2024)

Challenges and advances of immune checkpoint therapy
di: Lingyu Li, et al.
Pubblicazione: (2024)

Drug Sensitivity patterns across FAB subtypes and molecular mutations in AML: A comprehensive analysis for precision medicine
di: Mobina Shrestha, et al.
Pubblicazione: (2025)

An auxiliary diagnostic approach based on traditional Chinese medicine constitutions for older patients with frailty
di: Xuchao Gu, et al.
Pubblicazione: (2024)

Sex differences in structural cell‐mediated immune regulation: Implications for precision respiratory medicine
di: Quocdai Vu, et al.
Pubblicazione: (2026)

Targeting mutated KRAS in the first‐line therapy
di: Hideaki Ijichi
Pubblicazione: (2024)

Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
di: Yushan Huang, et al.
Pubblicazione: (2026)

High‐fat diet effects on brain mitochondrial complex I activity and protein lipoxidation: implications for translational medicine
di: Vetriselvan Subramaniyan, et al.
Pubblicazione: (2024)

EccDNA, STING activation, and their potential roles in DLBCL prognosis and therapy
di: Xi‐Bo Hu, et al.
Pubblicazione: (2024)

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy
di: Jing Zhao, et al.
Pubblicazione: (2025)

Utilisation of a national database to characterise renal function in patients with COVID19 infection
di: Nicholas R. Nelson, et al.
Pubblicazione: (2025)

CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
di: Dongchun Xie, et al.
Pubblicazione: (2024)

Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer
di: Haozhen Liu, et al.
Pubblicazione: (2024)

Sculpting nursing resilience: Transforming lives, nurturing ethics in chimeric antigen receptor T‐cell therapy
di: Pranay Bende
Pubblicazione: (2024)

A new metabolic signature to predict melanoma recurrence
di: Ngan K. Vu, et al.
Pubblicazione: (2024)